DEADLINE: June 5th, **Letter of intent is due two weeks prior to deadline
REPURPOSING DRUGS for ALZHEIMER'S DISEASE and RELATED DEMENTIAS RFP: The Alzheimer’s Drug Discovery Foundation (ADDF) and the Alzheimer’s Society (UK) are partnering together to issue this RFP to specially target the development of repurposed drugs for Alzheimer’s disease and other forms of dementia. See full RPF here.
DEADLINES for other 2014 RFPs:
**Letter of intent is due two weeks prior to deadline
PRECLINICAL DRUG DISOCVERY RFP: The ADDF accepts Letters of Intent (LOIs) for the “General Request for Proposals” research award programs throughout the year. 2014 deadlines for full proposals are March 5, June 5, September 5, and December 5. LOIs are due at least two weeks prior to the proposal deadlines. See full RFP here.
PACT RFP: The ADDF has created the Program to Accelerate Clinical Trials (PACT) to increase the number of innovative drugs tested in humans at the crucial proof of concept stage for Alzheimer’s disease. This program will fund biomarker-based, proof-of-concept pilot clinical trials for Alzheimer’s. 2014 deadlines for full proposals are March 5, June 5, September 5 and December 5. LOIs are due at least two weeks prior to the proposal deadlines. See full RFP here.
ADDF/NIH RFP: The ADDF will consider financial assistance for relevant NIH grant applications that were scored but not funded in response to certain NIH funding opportunities. Application deadline is rolling. See full RFP here.